๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Targeting therapy for glioma by LAK cells coupled with bispecific antibodies

โœ Scribed by Hishii, Makoto; Nitta, Taizo; Ebato, Michimasa; Okumura, Ko; Sato, Kiyoshi

Book ID
123194176
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
719 KB
Volume
1
Category
Article
ISSN
0967-5868

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Therapy for colon carcinoma xenografts w
Therapy for colon carcinoma xenografts with bispecific antibody-targeted, iodine-131-labeled bivalent hapten
โœ Emmanuel Gautherot; Jamila Bouhou; Jean-Marc Le Doussal; Corine Manetti; Marie M ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 147 KB

## METHODS. Nude mice grafted with LS174T human colorectal carcinoma were Epalinges, Switzerland. treated either with 111 megabecquerels (MBq) of iodine-131 labeled bivalent diethylenetriamine pentaacetic acid (DTPA) hapten 20 hours after pretargeting by anti-CEA 1 anti-DTPA-indium bispecific anti

Preclinical and clinical data with bispe
Preclinical and clinical data with bispecific antibodies recruiting myeloid effector cells for tumor therapy
โœ H.H van Ojik; T Valerius ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 199 KB

Bispecific antibodies constitute a novel approach to improve antibody efficacy. In vitro, constructs to recruit myeloid effector cells have been extensively investigated, and first animal data in human Fc receptor transgenic mice confirmed their promising therapeutic potential. Clinical experience w